• Shares of Bruker Corporation (NASDAQ:BRKR) traded higher on Wednesday after Frank Laukien, the chief executive officer of the life sciences firm, purchased over $5M worth of company stock.
• More than 1.6 million shares of Bruker (NASDAQ:BRKR) have changed hands compared to the 65-day average of ~1.2 million as the stock added ~5%, which, if the gain holds, would mark BRKR's best intraday advance in over five years.
• According to an SEC filing on Tuesday, Laukien, who has served as Bruker’s (BRKR) CEO for over thirty years, bought 100K company shares in three transactions.
• His purchases, made at prices ranging from $49.82 to $51.36 on average, were worth more than $5.0M in total.
• Following the transactions conducted on Monday, Laukien, the biggest shareholder of Bruker (BRKR), has increased his direct ownership of company shares to ~38.4 million.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。